Skip to main content
Journal cover image

Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans.

Publication ,  Journal Article
Hoiland, RL; Tremblay, JC; Stacey, BS; Coombs, GB; Nowak-Flück, D; Tymko, MM; Patrician, A; Stembridge, M; Howe, CA; Bailey, DM; Green, DJ ...
Published in: J Physiol
October 2020

Changes in haematocrit influence nitric oxide signalling through alterations in shear stress stimuli and haemoglobin scavenging of nitric oxide; these two regulatory factors have not been assessed simultaneously Isovolumic haemodilution led to a marked increase in brachial artery flow-mediated dilatation in humans The increase in flow-mediated dilatation occurred in the face of an unaltered shear stress stimulus for vasodilatation and reduced resting steady-state nitric oxide levels in the blood Collectively, our data point towards haemoglobin scavenging of nitric oxide as a key regulatory factor of brachial flow-mediated dilatation and highlight the importance of the simultaneous consideration of nitric oxide production and inactivation when investigating vascular function in humans ABSTRACT: Haemoglobin (Hb) may impact the transduction of endothelium-dependent and nitric oxide (NO)-mediated vasodilator activity, given its contribution to shear stress stimuli and diverse biochemical reactions with NO. We hypothesized that an acute reduction in [Hb] and haematocrit (Hct) would increase brachial artery flow-mediated dilatation (FMD). In 11 healthy males (28 ± 7 years; 23 ± 2 kg m-2 ), FMD (Duplex ultrasound), arterial blood gases, Hct and [Hb], blood viscosity, and NO metabolites (ozone-based chemiluminescence) were measured before and after isovolumic haemodilution, where ∼20% of whole blood was removed and replaced with 5% human serum albumin. Haemodilution reduced Hct by 18 ± 2% (P < 0.001) and whole blood viscosity by 22 ± 5% (P < 0.001). Plasma nitrite (P = 0.01), S-nitrosothiols (P = 0.03) and total red blood cell NO (P = 0.001) were collectively reduced by ∼15-40%. Brachial artery FMD increased by ∼160% from 3.8 ± 2.1 to 9.7 ± 4.5% (P = 0.004). Statistical covariation for the shear stress stimulus did not alter FMD, indicating that the increase in FMD was not directly related to alterations in whole blood viscosity and the shear stimulus. Collectively, these findings indicate that haemoglobin scavenging of NO appears to be an important factor in the regulation of FMD under normal conditions through constraint of endothelium-dependent NO-mediated vasodilatation in healthy humans.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Physiol

DOI

EISSN

1469-7793

Publication Date

October 2020

Volume

598

Issue

19

Start / End Page

4225 / 4236

Location

England

Related Subject Headings

  • Vasodilation
  • Regional Blood Flow
  • Physiology
  • Nitric Oxide
  • Male
  • Humans
  • Hematocrit
  • Endothelium, Vascular
  • Dilatation
  • Brachial Artery
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hoiland, R. L., Tremblay, J. C., Stacey, B. S., Coombs, G. B., Nowak-Flück, D., Tymko, M. M., … Ainslie, P. N. (2020). Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans. J Physiol, 598(19), 4225–4236. https://doi.org/10.1113/JP280141
Hoiland, Ryan L., Joshua C. Tremblay, Benjamin S. Stacey, Geoff B. Coombs, Daniela Nowak-Flück, Michael M. Tymko, Alexander Patrician, et al. “Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans.J Physiol 598, no. 19 (October 2020): 4225–36. https://doi.org/10.1113/JP280141.
Hoiland RL, Tremblay JC, Stacey BS, Coombs GB, Nowak-Flück D, Tymko MM, et al. Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans. J Physiol. 2020 Oct;598(19):4225–36.
Hoiland, Ryan L., et al. “Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans.J Physiol, vol. 598, no. 19, Oct. 2020, pp. 4225–36. Pubmed, doi:10.1113/JP280141.
Hoiland RL, Tremblay JC, Stacey BS, Coombs GB, Nowak-Flück D, Tymko MM, Patrician A, Stembridge M, Howe CA, Bailey DM, Green DJ, MacLeod DB, Ainslie PN. Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans. J Physiol. 2020 Oct;598(19):4225–4236.
Journal cover image

Published In

J Physiol

DOI

EISSN

1469-7793

Publication Date

October 2020

Volume

598

Issue

19

Start / End Page

4225 / 4236

Location

England

Related Subject Headings

  • Vasodilation
  • Regional Blood Flow
  • Physiology
  • Nitric Oxide
  • Male
  • Humans
  • Hematocrit
  • Endothelium, Vascular
  • Dilatation
  • Brachial Artery